+1 (855) PLE.XISION (753.9474) info@plexision.com

What We Do

You are here

Plexision currently offers cell-based testing for personalized assessment of rejection risk after solid organ transplantation The PleximmuneTM blood test is the first such test offered for children with liver or intestine transplantation.

Plexision’s technology can be adapted to -

  • assess disease risk for several immunological disorders
  • predict the success of a drug for a specific patient
  • develop dosing recommendations for new immunological drugs